FAQs

Hematopathology Fellowship FAQs

What are the training requirements for the fellowship?

All applicants must have completed an ACGME accredited residency program or an AOA approved residency program, with verification of the entering fellow’s level of competency at the time of matriculation into the fellowship. We require applicants to be eligible for the American Board of Pathology certifying exam or be certified in Anatomic and Clinical Pathology or Clinical Pathology alone from ACGME training obtained in the United States or Canada.

Do you require both USMLE and COMLEX scores for osteopathic applicants?

We require either USMLE or COMLEX and score transcripts from our osteopathic applicants.

Is there a minimum USMLE or COMPLEX score that I must attain before Beaumont, Royal Oak will consider my application?

We review all applications in their entirety, and we do not have a specific score requirement; however, applicants must have passed all of the USMLE or COMPLEX exams and hold a license, or be eligible to practice medicine in the State of Michigan. 

How many letters of reference are required?

We require 3 letters of reference, one from the Residency Program Director.

Does the fellowship take external rotators/observers?

Generally, no, due to the number of medical students and in-house non-Pathology residents and fellows that rotate through the department, the fellowship does not typically accept external pathology resident to rotate in just Hematopathology.

For international graduates, does Beaumont, Royal Oak sponsor the H-1B visa?

Beaumont sponsors H-1B visas for qualified applicants and also accepts J-1 visas sponsored by the ECFMG. Fellows wishing sponsorship under the terms of an H-1B visa must meet all of the requirements in sufficient time to have obtained the H1-B visa by the beginning of fellow orientation (typically the beginning of the third week in June). This requires premium processing of the H-1B visa application. If premium processing for the H-1B visa is not available from the USCIS, the resident must obtain a J-1 visa.